Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-22-000063

EVP, Quality & Ethics, and CPL acquired 11,826 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Glessner Coleen · EVP, Quality & Ethics, and CPL

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2022-04-08 Grant or award : show line 1 in the form +5,913 5,913 D
2022-04-08 Grant or award : show line 2 in the form +5,913 11,826 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-04-08 Grant or award : show line 3 in the form Employee Stock Options (Right to Buy) +23,651 $42.28 $999,964 23,651 D
Loading xslF345X03/wf-form4_164979397671420.xml…